Abstract
Introduction
Efforts to harmonize lipidomic methodologies have been limited within the community. Here, we aimed to capitalize on the recent National Institute of Standards and Technology lipidomics interlaboratory comparison exercise by implementing a questionnaire that assessed current methodologies, quantitation strategies, standard operating procedures (SOPs), and quality control activities employed by the lipidomics community.
Objectives
Lipidomics is a rapidly developing field with diverse applications. At present, there are no community-vetted methods to assess measurement comparability or data quality. Thus, a major impetus of this questionnaire was to profile current efforts, highlight areas of need, and establish future objectives in an effort to harmonize lipidomics workflows.
Methods
The 54-question survey inquired about laboratory demographics, lipidomic methodologies and SOPs, analytical platforms, quantitation, reference materials, quality control procedures, and opinions regarding challenges existing within the community.
Results
A total of 125 laboratories participated in the questionnaire. A broad overview of results highlighted a wide methodological diversity within current lipidomic workflows. The impact of this diversity on lipid measurement and quantitation is currently unknown and needs to be explored further. While some laboratories do incorporate SOPs and quality control activities, these concepts have not been fully embraced by the community. The top five perceived challenges within the lipidomics community were a lack of standardization amongst methods/protocols, lack of lipid standards, software/data handling and quantification, and over-reporting/false positives.
Conclusion
The questionnaire provided an overview of current lipidomics methodologies and further promoted the need for community-accepted guidelines and protocols. The questionnaire also served as a platform to help determine and prioritize metrological issues to be investigated.
Similar content being viewed by others
References
Beger, R. D., Dunn, W., Schmidt, M. A., Gross, S. S., Kirwan, J. A., Cascante, M., et al. (2016). Metabolomics enables precision medicine: A white paper, community perspective. Metabolomics, 12, 149.
Bowden, J. A., Heckert, A., Ulmer, C. Z., Jones, C. M., Koelmel, J. P., Abdullah, L., et al. (2017a). Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using standard reference material 1950 metabolites in frozen human plasma. Journal of Lipid Research. https://doi.org/10.1194/jlr.M079012.
Bowden, J. A., Ulmer, C. Z., Jones, C. M., & Heckert, N. A. (2017b). Lipid concentrations in standard reference material (SRM) 1950: Results from an interlaboratory comparison exercise for lipidomics. National Institute of Standards and Technology (NIST) IR 8185. http://nvlpubs.nist.gov/nistpubs/ir/2017/NIST.IR.8185.pdf.
Cajka, T., & Fiehn, O. (2014). Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. Trends in Analytical Chemistry: TRAC, 61, 192–206.
Dunn, W. B., Broadhurst, D. I., Edison, A., Guillou, C., Viant, M. R., Bearden, D. W. & Beger, R. D. (2017). Quality assurance and quality control processes: Summary of a metabolomics community questionnaire. Metabolomics, 13, 50.
Fahy, E., Subramaniam, S., Brown, H. A., Glass, C. K., Merrill, A. H., Murphy, R. C., et al. (2005). A comprehensive classification system for lipids. Journal of Lipid Research, 46,, 839–862.
Goodacre, R., Broadhurst, D., Smilde, A. K., Kristal, B. S., Baker, J. D., Beger, R. et al. (2007). Proposed minimum reporting standards for data analysis in metabolomics. Metabolomics, 3,, 231–241.
Guideline, I. H. T. (1998). ICH Harmonised Tripartite Guideline. International Conference on Hamonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Note for Guidance on Statistical Principles for Clinical Trials, ICH Topic E6 (R1), Current step 4 version.
Hyötyläinen, T., Ahonen, L., Pöhö, P., & Orešič, M. (2017). Lipidomics in biomedical research-practical considerations. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 1862(8), 800–803.
Koelmel, J. P., Ulmer, C. Z., Jones, C. M., Yost, R. A., & Bowden, J. A. (2017). Common cases of improper lipid annotation using high-resolution tandem mass spectrometry data and corresponding limitations in biological interpretation. Biochimica et Biophysica Acta (BBA): Molecular and Cell Biology of Lipids, 1862(8), 766–770.
Lam, S. M., Tian, H., & Shui, G. (2017). Lipidomics, en route to accurate quantitation. Biochimica et Biophysica Acta (BBA): Molecular and Cell Biology of Lipids, 1862(8), 752–761.
Liebisch, G., Ekroos, K., Hermansson, M., & Ejsing, C. S. (2017). Reporting of lipidomics data should be standardized. Biochimica et Biophysica Acta (BBA): Molecular and Cell Biology of Lipids, 1862, 747–751.
Liebisch, G., Vizcaíno, J. A., Köfeler, H., Trötzmüller, M., Griffiths, W. J., Schmitz, G., et al. (2013). Shorthand notation for lipid structures derived from mass spectrometry. Journal of Lipid Research, 54, 1523–1530.
Plebani, M. (2016). Harmonization of clinical laboratory information: Current and future strategies. EJIFCC, 27, 15–22.
Quehenberger, O., Armando, A. M., Brown, A. H., Milne, S. B., Myers, D. S., Merrill, A. H., et al. (2010). Lipidomics reveals a remarkable diversity of lipids in human plasma. Journal of Lipid Research, 51, 3299–3305.
Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., et al. (2007). Proposed minimum reporting standards for chemical analysis. Metabolomics, 3, 211–221.
Tate, J. R., & Myers, G. L. (2016). Harmonization of clinical laboratory test results. EJIFCC, 27, 5–14.
Wang, M., Wang, C., & Han, X. (2016). Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry: What, how and why? Mass Spectrometry Reviews, 36(6), 693–714.
Yang, K., & Han, X. (2011). Accurate quantification of lipid species by electrospray ionization mass spectrometry—meets a key challenge in lipidomics. Metabolites, 1, 21–40.
Acknowledgements
This study was partially funded by NIH Grant #U24 DK097209 (R.A.Y.). This research was done in collaboration between Core 1 and Core 3 of the Southeast Center for Metabolomics (SECIM) <http://secim.ufl.edu/>.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All other authors declare no conflicts of interest.
Research involving with human animal participants
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Disclaimer
Certain commercial equipment or instruments are identified in the paper to specify adequately the experimental procedures. Such identification does not imply recommendations or endorsement by NIST; nor does it imply that the equipment or instruments are the best available for the purpose.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bowden, J.A., Ulmer, C.Z., Jones, C.M. et al. NIST lipidomics workflow questionnaire: an assessment of community-wide methodologies and perspectives. Metabolomics 14, 53 (2018). https://doi.org/10.1007/s11306-018-1340-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11306-018-1340-1